Please login to the form below

Not currently logged in
Email:
Password:

Targin

This page shows the latest Targin news and features for those working in and with pharma, biotech and healthcare.

EC gives nod to restless leg syndrome drug Targin

EC gives nod to restless leg syndrome drug Targin

Mundipharma's Targin has been granted a licence in the EU for the treatment of restless leg syndrome (RLS). ... This new indication for Targin provides a much needed new treatment options for people with RLS who are not gaining sufficient relief from

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics